| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,640,169 ) |
| | 2025 | 2025 | SYNVIVIA, INC. | 5855 BEAUDRY ST | EMERYVILLE | CA | 94608-2605 | ALAMEDA | USA | R44GM158472 | Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes | 000 | 1 | NIH | 12/6/2024 | $1,640,169 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2016 | SYNVIVIA, INC. | 2341 GRANT ST UNIT B | BERKELEY | CA | 94703-2570 | ALAMEDA | USA | R43DK112475 | Genetically Encoded Biosafety in a Therapeutically Modified Organism for Obesity | 000 | 1 | NIH | 1/15/2019 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $295,172 ) |
| | 2016 | 2016 | SYNVIVIA, INC | 2341 GRANT ST UNIT B | BERKELEY | CA | 94703-2570 | ALAMEDA | USA | R43DK112475 | Genetically Encoded Biosafety in a Therapeutically Modified Organism for Obesity | 000 | 1 | NIH | 9/22/2016 | $295,172 |
|
|
